community levels of COVID-19 infection<\/a> are moderate or high, or if you are at increased risk for severe infection.<\/li>\r\n\t<li><a href=https://www.health.harvard.edu/"https:////www.cdc.gov//coronavirus//2019-ncov//prevent-getting-sick//prevention.html#ventilation\">Improve indoor ventilation<\/a>.<\/li>\r\n\t<li>Get tested for COVID-19 if needed.<\/li>\r\n\t<li>Stay home if you have suspected or confirmed COVID-19.<\/li>\r\n\t<li>Avoid contact with people who have suspected or confirmed COVID-19.<\/li>\r\n\t<li><a href=https://www.health.harvard.edu/"https:////www.cdc.gov//coronavirus//2019-ncov//prevent-getting-sick//prevention.html/">Follow recommendations<\/a> for what to do if you have been exposed.<\/li>\r\n\t<li>Seek treatment if you have COVID-19 and are at high risk of getting very sick.<\/li>\r\n<\/ul>"},{"order":1,"title":"What is coronavirus?","content":"<p>Coronaviruses are an extremely common cause of colds and other upper respiratory infections. SARS-CoV-2, short for severe acute respiratory syndrome coronavirus 2, is the official name for the coronavirus responsible for COVID-19.<\/p>"},{"order":2,"title":"What is COVID-19?","content":"<p>COVID-19, short for "coronavirus disease 2019," is the name of the disease caused by the SARS-CoV-2 coronavirus.<\/p>"},{"order":3,"title":"How many people have COVID-19?","content":"<p>The numbers are changing rapidly.<\/p>\r\n\r\n<p>The most up-to-date information is available from the <a href=https://www.health.harvard.edu/"https:////www.who.int//emergencies//diseases//novel-coronavirus-2019//situation-reports///" target=\"_blank\">World Health Organization<\/a>, the <a href=https://www.health.harvard.edu/"https:////www.cdc.gov//coronavirus//2019-ncov//cases-in-us.html/" target=\"_blank\">US Centers for Disease Control and Prevention<\/a>, and <a href=https://www.health.harvard.edu/"https:////urldefense.proofpoint.com//v2//url?u=https-3A__www.arcgis.com_apps_opsdashboard_index.html-23_bda7594740fd40299423467b48e9ecf6&d=DwMF-g&c=WO-RGvefibhHBZq3fL85hQ&r=7DVYAyfgxYC9a8hZlpV7pHQav5syXVQFU6Wt6FNPLGA&m=gjg2Esgb2K3_z_T8A06LJe_bhEkFI2PHfBwPrEqlsQ8&s=AN5Hf6qM7XqjwnR1dOTA0lf3HnOXMCA0tzTakQ489CE&e=\%22 target=\"_blank\">Johns Hopkins University<\/a>.<\/p>\r\n\r\n<p>In March 2020, the World Health Organization declared COVID-19 a pandemic (a term indicating that it has affected a large population, region, country, or continent).<\/p>"},{"order":4,"title":"What are the symptoms of COVID-19?","content":"<p>Symptoms of COVID-19 infection have evolved over time. Common symptoms of the XBB.1.5 Omicron variant include fever, chills, fatigue, muscle or body aches, and sore throat. In some people, COVID-19 causes more severe symptoms like high fever, severe cough, and shortness of breath, which may indicate pneumonia. Some people infected with the virus have no symptoms.<\/p>\r\n\r\n<p>People infected with the newer COVID-19 can also experience neurological, muscular, and\/or gastrointestinal (GI) symptoms These may occur with or without respiratory symptoms. Similar to respiratory symptoms, these other problems have also tended to be less severe than those caused by the original virus. Neurological and muscular symptoms seen in people with COVID-19 include muscle weakness and tingling. Loss of smell and diminished taste have become less common with more recent variants. GI symptoms from all COVID-19 variants include loss of appetite, nausea, vomiting, and diarrhea.<\/p>"},{"order":5,"title":"Do adults younger than 65 who are otherwise healthy need to worry about COVID-19?","content":"<p>Yes, they do. Although the risk of serious illness or death from COVID-19 increases steadily with age, younger people can get sick enough from the disease to require hospitalization. And certain underlying medical conditions may increase the risk of serious COVID-19 for individuals of any age.<\/p>\r\n\r\n<p>Everyone, including younger and healthier people, should get the vaccine once they are eligible, to protect both themselves and their community. Vaccines offer excellent (though not complete) protection against moderate to severe disease, hospitalization, and death.<\/p>\r\n\r\n<p>In addition, the CDC advises everyone — vaccinated and unvaccinated — to wear masks in public indoor places in areas of the country with substantial or high transmission of the virus. The CDC also advises anyone at increased risk to wear a mask indoors, regardless of the level of community transmission. For people who are not fully vaccinated, the CDC continues to recommend mask wearing and other preventive measures such as physical distancing in some outdoors settings and in most indoor settings.<\/p>\r\n\r\n<p>To check the level of virus transmission in your area, <a href=https://www.health.harvard.edu/"https:////covid.cdc.gov//covid-data-tracker//#county-view\" target=\"_blank\">visit the CDC's COVID Data Tracker.<\/a><\/p>"},{"order":6,"title":"To what extent have younger adults been impacted by COVID-19?","content":"<p>According to the CDC's <a href=https://www.health.harvard.edu/"https:////covid.cdc.gov//covid-data-tracker//#datatracker-home\" target=\"_blank\">COVID Data Tracker<\/a>, through mid-November 2021, about 38% of COVID cases in the US have been in adults aged 18 to 39 years. However, younger adults are less likely than older adults to die of COVID-19: Adults in the 18 to 39 age range account for about 2.4% of COVID deaths, compared to 76.8% for people older than 65.<\/p>\r\n\r\n<p>But younger people <em>can<\/em> get sick enough from the disease to require hospitalization or to die. And they may be among the long haulers — people who continue to experience fatigue, brain fog, shortness of breath, or other symptoms weeks and months after their illness.<\/p>\r\n\r\n<p>And as is true in other age groups, COVID illness and death has a disproportionate impact on younger adults of color.<\/p>\r\n\r\n<p>Everyone, including younger and healthier people, should get the vaccine once they are eligible.<\/p>"},{"order":7,"title":"How soon can a person exposed to the virus expect symptoms to start?","content":"<p>The time from exposure to symptom onset (known as the incubation period) for XBB.1.5, the most commonly circulating variant as of April 2023, is usually within three to five days. Importantly, a person infected with the virus is already contagious one to two days before symptom onset, and remains contagious for at least two to three days after symptoms begin.<\/p>"},{"order":8,"title":"Can COVID-19 symptoms worsen rapidly after several days of illness?","content":"<p>Common symptoms of COVID-19 include fever, dry cough, fatigue, loss of appetite, loss of smell, and body ache. In some people, COVID-19 causes more severe symptoms like high fever, severe cough, and shortness of breath, which often indicates pneumonia.<\/p>\r\n\r\n<p>A person may have mild symptoms for about one week, then worsen rapidly. Let your doctor know if your symptoms quickly worsen over a short period of time. Also call the doctor right away if you or a loved one with COVID-19 experience any of the following emergency symptoms: trouble breathing, persistent pain or pressure in the chest, confusion or inability to arouse the person, or bluish lips or face.<\/p>"},{"order":9,"title":"One of the symptoms of COVID-19 is shortness of breath. What does that mean?","content":"<p>Shortness of breath refers to unexpectedly feeling out of breath, or winded. But when should you worry about shortness of breath? There are many examples of temporary shortness of breath that are not worrisome. For example, if you feel very anxious, it's common to get short of breath and then it goes away when you calm down.<\/p>\r\n\r\n<p>However, if you find that you are ever breathing harder or having trouble getting air each time you exert yourself, you always need to call your doctor. That was true before we had COVID-19, and it will still be true after it is over.<\/p>"},{"order":10,"title":"Is a lost sense of smell a symptom of COVID-19? What should I do if I lose my sense of smell?","content":"<p>A lost sense of smell, known medically as anosmia, is a common symptom of COVID-19. This is not surprising, because viral infections are a leading cause of loss of sense of smell, and COVID-19 is a caused by a virus. Still, loss of smell with COVID-19 appears to occur much more often compared to other viral infections. So, this symptom may help doctors identify people who do not have other symptoms, but who might be infected with the COVID-19 virus — and who might be unwittingly infecting others.<\/p>\r\n\r\n<p>In addition to COVID-19, loss of smell can also result from allergies as well as other viruses, including rhinoviruses that cause the common cold. So anosmia alone does not mean you have COVID-19.<\/p>\r\n\r\n<p>Tell your doctor right away if you find yourself newly unable to smell. He or she may prompt you to get tested and to self-isolate.<\/p>\r\n\r\n<p>A November 2021 report published in <em>JAMA Otolaryngology – Head and Neck Surgery<\/em> found that between 700,000 and 1.6 million people in the US have experienced COVID-related loss or impaired sense of smell that lasted more than six months.<\/p>\r\n\r\n<p>In nearly all cases, however, sense of smell returns within one year. A study of nearly 100 COVID patients who lost their sense of smell found that 86% recovered their sense of smell by six months after infection, and 96% recovered their sense of smell within 12 months after infection.<\/p>"},{"order":11,"title":"What are cytokine storms and what do they have to do with COVID-19?","content":"<p>A cytokine storm is an overreaction of the body's immune system. In some people with COVID-19, the immune system releases immune messengers, called cytokines, into the bloodstream out of proportion to the threat or long after the virus is no longer a threat.<\/p>\r\n\r\n<p>When this happens, the immune system attacks the body's own tissues, potentially causing significant harm. A cytokine storm triggers an exaggerated inflammatory response that may damage the liver, blood vessels, kidneys, and lungs, and increase formation of blood clots throughout the body. Ultimately, the cytokine storm may cause more harm than the coronavirus itself.<\/p>\r\n\r\n<p>A simple blood test can help determine whether someone with COVID-19 may be experiencing a cytokine storm. Many doctors, including those in the United States, have been treating very ill COVID-19 patients with dexamethasone and other corticosteroids (prednisone, methylprednisolone). Corticosteroids are potent anti-inflammatory drugs and thus make biologic sense for those patients who have developed an exaggerated inflammatory response to the viral infection.<\/p>"},{"order":12,"title":"Does COVID-19 cause strokes? What about blood clots in other parts of the body?","content":"<p>Strokes occur when the brain's blood supply is interrupted, usually by a blood clot. There have been reports of a greater-than-expected number of younger patients being hospitalized for, and sometimes dying from, serious strokes. These strokes are happening in patients who test positive for coronavirus but who do not have any traditional risk factors for stroke. They tend to have no COVID-19 symptoms, or only mild symptoms. The type of stroke occurring in these patients typically occurs in much older patients.<\/p>\r\n\r\n<p>COVID-related strokes occur because of a body-wide increase in blood clot formation, which can damage any organ, not just the brain. A blood clot in the lungs is called pulmonary embolism and can cause shortness of breath, chest pain, or death; a blood clot in or near the heart can cause a heart attack; and blood clots in the kidneys can cause kidney damage requiring dialysis.<\/p>\r\n\r\n<p>One possible reason for COVID-related blood clots may be a disturbance in the levels of a protein, called factor V, that is involved in blood clotting.<\/p>"},{"order":13,"title":"Can COVID-19 affect brain function?","content":"<p>COVID-19 does appear to affect brain function in some people. Specific neurological symptoms seen in people with COVID-19 include loss of smell, inability to taste, muscle weakness, tingling or numbness in the hands and feet, dizziness, confusion, delirium, seizures, and stroke.<\/p>\r\n\r\n<p>One study that looked at 214 people with moderate to severe COVID-19 in Wuhan, China found that about one-third of those patients had one or more neurological symptoms. Neurological symptoms were more common in people with more severe disease.<\/p>\r\n\r\n<p>Neurological symptoms have also been seen in COVID-19 patients in the US and around the world. Some people with neurological symptoms tested positive for COVID-19 but did not have any respiratory symptoms like coughing or difficulty breathing; others experienced both neurological and respiratory symptoms.<\/p>\r\n\r\n<p>Experts do not know how the coronavirus causes neurological symptoms. They may be a direct result of infection or an indirect consequence of inflammation or altered oxygen and carbon dioxide levels caused by the virus.<\/p>\r\n\r\n<p>"New confusion or inability to rouse" is on the CDC’s list of emergency warning signs that should prompt you to get immediate medical attention.<\/p>"},{"order":14,"title":"How does coronavirus spread?","content":"<p>The coronavirus spreads mainly from person to person. A person infected with coronavirus — even one with no symptoms — may emit aerosols when they talk or breathe. Aerosols are infectious viral particles that can float or drift around in the air for up to three hours. Another person can breathe in these aerosols and become infected with the coronavirus.<\/p>\r\n\r\n<p>When people are in close contact with one another, droplets that are produced when an infected person coughs or sneezes may land in the mouths or noses of people who are nearby, or possibly be inhaled into their lungs.<\/p>\r\n\r\n<p>Transmission is less likely to happen outdoors, where air currents scatter and dilute the virus, than in a home, office, or other confined space with limited air circulation.<\/p>\r\n\r\n<p>The risk of spread from contact with contaminated surfaces or objects is considered to be extremely low. According to the CDC, each contact with a contaminated surface has less than a 1 in 10,000 chance of causing an infection.<\/p>\r\n\r\n<p>The virus may be shed in saliva, semen, and feces; whether it is shed in vaginal fluids isn't known. Kissing can transmit the virus. Transmission of the virus through feces, or during vaginal or anal intercourse or oral sex, appears to be extremely unlikely at this time.<\/p>"},{"order":15,"title":"I\u2019m vaccinated but got a breakthrough COVID infection. Can I still spread the infection to others?","content":"<p>Yes, you can. That's why the CDC recommends that everyone who tests positive for COVID-19 should isolate from others for at least five days, regardless of their vaccination status.<\/p>"},{"order":16,"title":"Can people without symptoms spread the virus to others?","content":"<p>"Without symptoms" can refer to two groups of people: those who eventually do have symptoms (pre-symptomatic) and those who never go on to have symptoms (asymptomatic). During this pandemic, we have seen that people without symptoms can spread the coronavirus infection to others.<\/p>\r\n\r\n<p>A person with COVID-19 may be contagious 48 hours before starting to experience symptoms. In fact, people without symptoms may be more likely to spread the illness, because they are unlikely to be isolating and may not adopt behaviors designed to prevent spread.<\/p>\r\n\r\n<p>But what about people who never go on to develop symptoms? A study <a href=https://www.health.harvard.edu/"https:////pubmed.ncbi.nlm.nih.gov//33410879///" target=\"_blank\">published in <em>JAMA Network Open<\/em><\/a> found that almost one out of every four infections may be transmitted by individuals with asymptomatic infections. The proportion of asymptomatic transmission appears to be even higher with the Omicron variant.<\/p>\r\n\r\n<p>Getting vaccinated and boosted once you are eligible is important for protecting not just yourself but others as well; evidence suggests that you're less likely to infect others, or may be contagious for a shorter period of time, once you've been vaccinated.<\/p>"},{"order":17,"title":"Are kids any more or less likely than adults to spread coronavirus?","content":"<p>Most children who become infected with the COVID-19 virus have no symptoms, or they have milder symptoms such as low-grade fever, fatigue, and cough. Early studies suggested that children do not contribute much to the spread of coronavirus. But more recent studies indicate that children are capable of spreading the infection.<\/p>\r\n\r\n<p>Though the studies varied in their methods, their findings were similar: infected children had as much, or more, coronavirus in their upper respiratory tracts as infected adults. And a November 2021 study conducted by Harvard researchers again confirmed that children carry live virus capable of infecting others.<\/p>\r\n\r\n<p>The amount of virus found in children — their viral load — was not correlated with the severity of their symptoms. In other words, a child with mild or no symptoms may have just as many viral particles in their nose and mouth as a child that has more severe symptoms. So, the presence of a high viral load in infected children increases the likelihood that children, even those without symptoms, could readily spread the infection to others.<\/p>\r\n\r\n<p>The bottom line? Public health measures are as important for kids and teens as they are for adults.<\/p>"},{"order":18,"title":"What does the CDC's definition of \"close contacts\" mean for me?","content":"<p>The CDC defines a close contact as someone who spends 15 minutes or more within six feet of a person with COVID-19 <em>over a period of 24 hours<\/em>.<\/p>\r\n\r\n<p>Close contacts are at increased risk of infection. When a person tests positive for COVID-19, contact tracers may identify their close contacts and notify them that they have been exposed.<\/p>\r\n\r\n<p>Many factors can affect the chances that infection will spread from one person to another. These factors include whether or one or both people are wearing masks, whether the infected person is coughing or showing other symptoms, and whether the encounter occurred indoors or outdoors.<\/p>"},{"order":19,"title":"How could contact tracing help slow the spread of COVID-19?","content":"<p>Anyone who comes into close contact with someone who has COVID-19 is at increased risk of becoming infected themselves, and of potentially infecting others. Contact tracing can help prevent further transmission of the virus by quickly identifying and informing people who may be infected and contagious, so they can take steps to not infect others.<\/p>\r\n\r\n<p>Contact tracing begins with identifying everyone that a person recently diagnosed with COVID-19 has been in contact with since they became contagious. In the case of COVID-19, a person may be contagious 48 to 72 hours before they started to experience symptoms.<\/p>\r\n\r\n<p>The contacts are notified about their exposure. They may be told what symptoms to look out for, advised on when to get tested for the virus, whether and for how long to isolate themselves, and to seek medical attention as needed if they start to experience symptoms.<\/p>"},{"order":20,"title":"How long can the coronavirus stay airborne? I have read different estimates.","content":"<p>A study done by National Institute of Allergy and Infectious Diseases' Laboratory of Virology in the Division of Intramural Research in Hamilton, Montana helps to answer this question. The researchers used a nebulizer to blow coronaviruses into the air. They found that infectious viruses could remain in the air for up to three hours. The results of the study were published in the <em>New England Journal of Medicine<\/em> on March 17, 2020.<\/p>"},{"order":21,"title":"Can the COVID-19 virus spread through air conditioning?","content":"<p>We don't know for certain if the COVID-19 virus spreads through air conditioning. But we do know that when it's hot and humid, people are more likely to stay indoors, with the windows closed — giving the virus more opportunity to spread.<\/p>\r\n\r\n<p>Coronavirus spreads through droplets that an infected person emits through coughs or sneezes and through smaller, infectious viral particles that can drift around in the air for several hours. Outdoors, air currents can scatter and dilute the virus, making transmission less likely. You're more likely to inhale the virus indoors, with the windows closed, whether or not you have the air conditioning on.<\/p>\r\n\r\n<p>If you are indoors with anyone outside of your household, increase air circulation by keeping the windows open as much as possible.<\/p>"},{"order":22,"title":"Can I catch the coronavirus by eating food handled or prepared by others?","content":"<p>According to the CDC, the risk of getting COVID-19 by handling or consuming food from a restaurant, takeout, or drive-through is very low.<\/p>"},{"order":23,"title":"What is the naming system for COVID-19 variants?","content":"<p>The WHO announced a new naming system for COVID-19 variants in May 2021. The new names are intended to be easier to pronounce and will remove the stigma of a variant’s being associated with a particular country.<\/p>\r\n\r\n<p>Under the new system, the variants will be named using letters of the Greek alphabet. For example:<\/p>\r\n\r\n<ul>\r\n\t<li>Alpha is the new name for the B.1.1.7 variant, first documented in the United Kingdom.<\/li>\r\n\t<li>Beta is the new name for the B.1.351 variant, first documented in South Africa.<\/li>\r\n\t<li>The P.1 variant, first documented in Brazil, will now be known as Gamma.<\/li>\r\n\t<li>The B.1.617.2 variant, first documented in India, will be called Delta.<\/li>\r\n<\/ul>\r\n\r\n<p>For a complete list of new SARS-CoV-2 variant names, <a href=https://www.health.harvard.edu/"https:////www.who.int//en//activities//tracking-SARS-CoV-2-variants///" target=\"_blank\">click here<\/a>.<\/p>\r\n\r\n<p>Scientists will likely continue referring to variants by strings of letters and numbers, which provide information about a variant’s lineage.<\/p>"},{"order":24,"title":"What do we know about the Omicron variant?","content":"<p>The Omicron variant, also known as B.1.1.529, is now the most common SARS-CoV-2 variant in the US. This variant has about 50 mutations, including more than 30 mutations on the spike protein, the region of the virus that binds to and allows the virus to enter human cells. Here’s what we know about it.<\/p>\r\n\r\n<p><strong>How transmissible is Omicron?<\/strong><\/p>\r\n\r\n<p>Dr. Anthony Fauci, Chief Medical Advisor to the President of the US, said in a White House press briefing, "…we know now incontrovertibly that this is a highly, highly transmissible virus…" A report from the United Kingdom found that someone infected with the Omicron variant is three times more likely to infect a member of their household than someone infected with the Delta variant. According to the CDC, most transmission occurs in the one to two days before symptoms begin and the two to three days after.<\/p>\r\n\r\n<p><strong>How well does Omicron evade protection from vaccines?<\/strong><\/p>\r\n\r\n<p>Several studies, including some presented at a <a href=https://www.health.harvard.edu/"https:////www.who.int//news-room//events//detail//2021//12//15//default-calendar//who-global-consultation---what-evidence-do-we-have-that-omicron-is-evading-immunity-and-what-are-the-implications/" target=\"_blank\">WHO meeting<\/a> in mid-December, have shown that two doses of an mRNA vaccine like Pfizer\/BioNTech or Moderna do not protect as well against infection with Omicron as they did against previous SARS-CoV-2 variants.<\/p>\r\n\r\n<p>One small laboratory study conducted by researchers in South Africa, for example, found a 41-fold decrease in neutralization (the ability of antibodies to prevent the virus from infecting cells) with Omicron compared to the earlier coronavirus variant. Pfizer\/BioNTech also released data from a laboratory study showing a significantly decreased antibody response to Omicron after two vaccine doses.<\/p>\r\n\r\n<p>This all suggests that Omicron is more capable of causing breakthrough infections (in people who are vaccinated) and reinfections (in people who were previously infected).<\/p>\r\n\r\n<p>More promising findings from Pfizer\/BioNTech showed that after three vaccine doses (two doses plus a booster), the neutralizing antibody response was much stronger. Preliminary research from the National Institute of Allergy and Infectious Disease’s Vaccine Research Center, conducted in the lab using the Moderna vaccine, similarly showed that boosters increase antibody-derived protection.<\/p>\r\n\r\n<p>The benefit of boosters is also being seen in the real world. In one preprint study (not yet peer-reviewed or published), researchers in the United Kingdom showed that protection against infection and mild disease increased from about 40% four months after two Pfizer\/BioNTech shots to about 75% within two weeks after a booster dose. This study took place during a time when Omicron cases were rising in the UK.<\/p>\r\n\r\n<p>How might boosters help? Booster-generated antibodies are not more specific to the Omicron variant. But the sheer increase in antibody levels helps enhance our immunity.<\/p>\r\n\r\n<p>What’s more, the vaccines continue to significantly protect against severe symptoms, hospitalization, and death, especially for people who have received a booster. That’s because in addition to stimulating an antibody response, vaccines also stimulate production of T cells, a type of immune cell that attacks infected cells. In a preprint study, an international team of researchers showed that the T cell response holds up well in people who are vaccinated or were previously infected with SARS-CoV-2. Specifically, the researchers found that CD4 and CD8 T cells retained 70% to 80% of their response to Omicron.<\/p>\r\n\r\n<p><strong>Is Omicron more or less virulent than previous variants?<\/strong><\/p>\r\n\r\n<p>Lab studies, animal studies, and epidemiological data all indicate that Omicron may cause less severe disease than previous variants, and a few of the studies provide clues as to why that may be the case. A team of researchers in Hong Kong, for example, wrote in a preprint study that the Omicron virus replicates more quickly in the bronchi (tubes that deliver air from the windpipe to the lungs) than it does in the lungs themselves. This is significant because once in the lungs, the virus can lead to scarring and difficulty breathing, and trigger widespread inflammation. The Hong Kong study was conducted in a laboratory on human tissue. Animal studies in mice and hamsters also show more viral replication in the upper airway compared to the lungs, and less clinical illness (in these animals, that means less weight loss, lung damage, and death).<\/p>\r\n\r\n<p>In real-world findings, data from the United Kingdom show significant reduction in the risk of hospitalization from Omicron compared to Delta, and data from the US show that even after accounting for a time lag, hospitalizations and deaths are not increasing in proportion to the increased number of infections.<\/p>\r\n\r\n<p>There are probably many reasons for the reduced disease severity we’re seeing, including some protection from vaccines and previous infections, as well as the likelihood that this variant inherently causes less severe disease than previous variants.<\/p>\r\n\r\n<p>Still, two things are important to consider: First, this variant is more transmissible, so even if it is not as dangerous, it will lead to a larger number of severe illnesses, hospitalizations, and deaths, based simply on the increased number of people it infects. And second, the risk of severe disease with Omicron is much higher in people who are not vaccinated.<\/p>\r\n\r\n<p><strong>Which preventive health measures are effective?<\/strong><\/p>\r\n\r\n<p>First and foremost, get vaccinated and boosted. The evidence is clear that booster shots sharply increase antibody levels, which helps fend off infection and illness.<\/p>\r\n\r\n<p>Preventive health measures build upon one another, and the same measures that helped protect against previous variants protect against Omicron. In addition to getting vaccinated, everyone should<\/p>\r\n\r\n<ul>\r\n\t<li>wear a well-fitting, high-quality mask<\/li>\r\n\t<li>wash hands frequently<\/li>\r\n\t<li>physically distance from others<\/li>\r\n\t<li>improve indoor ventilation (open windows, etc.)<\/li>\r\n\t<li>avoid crowded spaces.<\/li>\r\n<\/ul>"},{"order":25,"title":"What do I need to know about the Delta variant?","content":"<p>The Delta variant is different from previous SARS-CoV-2 variants that have made their way to the US. It’s highly contagious and may cause more severe disease. It is also more likely than previous variants to be spread by vaccinated people experiencing breakthrough infections.<\/p>\r\n\r\n<p>Evidence presented to the CDC showed the Delta variant to be much more contagious than previous variants, with a risk of transmission similar to chickenpox. It also appears that people who are infected can spread the virus for longer periods of time.<\/p>\r\n\r\n<p>In addition, people who are vaccinated and then get infected (breakthrough infections) can also spread the virus to others, perhaps to the same extent as those who are unvaccinated. However, people with breakthrough infections appear to be contagious for a shorter period of time.<\/p>\r\n\r\n<p>Finally, international studies point to the Delta variant being more likely to cause severe disease.<\/p>\r\n\r\n<p>The good news is that while vaccination may be less effective at preventing infection and spread of the Delta variant, it is still highly protective against severe disease, hospitalization, and death. Get the COVID-19 vaccine if you have not already done so.<\/p>\r\n\r\n<p>In July 2021, the CDC advised all people — vaccinated and unvaccinated — to wear masks in public indoor places, in areas of the country with substantial or high transmission of the virus. Given the threat posed by the Delta variant, it’s reasonable for everyone to start wearing a mask in indoor public spaces, regardless of the level of virus in your area.<\/p>\r\n\r\n<p>Masks reduce the amount of virus we breathe in, and breathe out. Combined with the vaccine, masks provide a one-two punch that reduces the risk of spread — to children who are not yet eligible for vaccines, to people with weakened immune systems, and to others who are unvaccinated. Masks also provide additional protection for the wearer, including who are fully vaccinated.<\/p>"},{"order":26,"title":"What do I need to know about the AY.4.2 (Delta Plus) variant?","content":"<p>As viruses replicate, they may mutate, or slightly alter their genetic sequence. If a mutation is advantageous — making the virus more transmissible or able to sidestep immune protection — it’s more likely to survive and thrive. That’s what happened with the Delta variant, which was many times more contagious than the original SARS-CoV-2 virus and quickly became the dominant variant around the globe. A new variant called AY.4.2 (or Delta Plus), a descendent of the Delta variant, is now gaining attention.<\/p>\r\n\r\n<p>The AY.4.2 variant makes up about 11% of sequenced cases in the United Kingdom. It has also been identified in a handful of US states, but at present is responsible for less than 0.1% of COVID-19 cases in the US. The WHO has not classified AY.4.2 as a variant of concern or a variant of interest.<\/p>\r\n\r\n<p>Preliminary evidence from the United Kingdom suggests that AY.4.2 is not more likely to lead to hospitalization or cause severe disease. And in a White House briefing, the CDC director said there is no evidence that this variant is less susceptible to current vaccines and treatments. It also does not appear more adept at evading immune protection.<\/p>\r\n\r\n<p>However, there is a lot we still don’t know about the AY.4.2 variant, including whether and to what extent it is more transmissible than the original Delta variant. At this point, it appears to be only slightly more contagious (10% to 15%). Its spread may also be influenced by human behaviors, such as whether people are masking indoors and the degree to which people in a community are vaccinated.<\/p>\r\n\r\n<p>It seems very likely that we will be living with this virus, and its variants, for some time to come. The best way to minimize the emergence of new variants, and to protect ourselves from variants that already exist, is to vaccinate as many people around the world as possible. Why? Because the less the virus spreads, the less opportunity it has to replicate and mutate. For the same reason, it’s vital to mask indoors, optimize ventilation, get tested if you have symptoms or are exposed to someone with COVID-19, and isolate if you test positive.<\/p>"},{"order":27,"title":"Which vaccines has the FDA approved and authorized for COVID-19?","content":"<p>The FDA has granted full approval to the mRNA COVID-19 vaccines developed by Pfizer\/BioNTech and Moderna, and has granted emergency use authorization (EUA) to Johnson & Johnson's adenovirus vaccine. In May 2022, the FDA limited use of the Johnson & Johnson vaccine to adults who cannot get, or refuse to get, one of the mRNA vaccines.<\/p>\r\n\r\n<p>The Pfizer\/BioNTech and Moderna vaccines have also been authorized for children ages 6 months and older.<\/p>\r\n\r\n<p>In addition, booster doses of the Pfizer\/BioNTech and Moderna vaccines have been authorized for eligible children ages 5 years and older.<\/p>"},{"order":28,"title":"Should I get a flu shot?","content":"<p>While the flu shot won't protect you from developing COVID-19, it's still a good idea. Most people older than six months can and should get the flu vaccine. Doing so reduces the chances of getting seasonal flu. Even if the vaccine doesn't prevent you from getting the flu, it can decrease the chance of severe symptoms. But again, the flu vaccine will not protect you against COVID-19.<\/p>"},{"order":29,"title":"Is it safe to use steroids to control allergy and asthma symptoms during the COVID-19 pandemic?","content":"<p>Yes, it is safe to use corticosteroid nasal sprays to control nasal allergies or inhaled corticosteroids to control asthma symptoms during the COVID-19 pandemic.<\/p>\r\n\r\n<p>The American College of Allergy, Asthma and Immunology (ACAAI) issued a statement emphasizing the importance of controlling allergy and asthma symptoms during the pandemic. They said there is no evidence that intranasal or inhaled corticosteroids increase the risk of getting the COVID-19 infection or lead to a worse outcome if you do get infected.<\/p>\r\n\r\n<p>The ACAAI statement was a response to concerns over reports warning against the use of systemic steroids to treat hospitalized COVID-19 patients with specific respiratory complications. However, those reports did not refer to healthy individuals using corticosteroid nasal sprays or inhalers to manage allergies or asthma.<\/p>"}])"
>
FAQs
Additional information on coronavirus and COVID-19 can be found on other pages within the Resource Center.
searching:
results out of
No results matched your search.